- Previous Close
0.0100 - Open
0.0100 - Bid 0.0110 x --
- Ask 0.0150 x --
- Day's Range
0.0100 - 0.0100 - 52 Week Range
0.0070 - 0.0350 - Volume
252,893 - Avg. Volume
217,282 - Market Cap (intraday)
3.699M - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is headquartered in Melbourne, Australia.
www.hydralyte.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HPC.AX
View MorePerformance Overview: HPC.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HPC.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HPC.AX
View MoreValuation Measures
Market Cap
3.70M
Enterprise Value
7.81M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.84
Enterprise Value/Revenue
1.53
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
83.23%
Return on Assets (ttm)
-44.88%
Return on Equity (ttm)
-476.06%
Revenue (ttm)
3.2M
Net Income Avi to Common (ttm)
-5.67M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
3.22M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.55M